Immune system changes during COVID-19 recovery play key role in determining disease severity

F Fathi, R Sami, S Mozafarpoor… - International journal …, 2020 - journals.sagepub.com
Coronavirus disease 2019 (COVID-19), an acute respiratory infection, is largely associated
with dysregulation and impairment of the immune system. This study investigated how the …

Immunological characteristics of non-intensive care hospitalized COVID-19 patients: A preliminary report

S Corrao, F Gervasi, F Di Bernardo, G Natoli… - Journal of Clinical …, 2021 - mdpi.com
The outbreak of coronavirus disease 2019 (COVID-19) is posing a threat to global health.
This disease has different clinical manifestations and different outcomes. The immune …

Understanding the immunological aspects of SARS-CoV-2 causing COVID-19 pandemic: A therapeutic approach

A Das, S Roy, S Swarnakar, N Chatterjee - Clinical Immunology, 2021 - Elsevier
Abstract In December 2019, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-
2), a novel variant of coronavirus has emerged from Wuhan in China and has created havoc …

Long-term infection of SARS-CoV-2 changed the body's immune status

L Lin, S Luo, R Qin, M Yang, X Wang, Q Yang… - Clinical …, 2020 - Elsevier
The outbreak of SARS-CoV-2-associated pneumonia, a disease called COVID-19, has
caused a pandemic worldwide. To investigate the immune responses after infection of SARS …

[HTML][HTML] Prolonged humoral and cellular immunity in COVID-19-recovered patients

MA Alsayb, ADD Alsamiri, HQ Makhdoom… - Saudi journal of …, 2021 - Elsevier
By the beginning of 2021, the battle against coronavirus disease 2019 (COVID-19) remains
ongoing. Investigating the adaptive immune response against severe acute respiratory …

[PDF][PDF] High expression of ACE2 in the human lung leads to the release of IL6 by suppressing cellular immunity: IL6 plays a key role in COVID-19.

Z Bao, LJ Wang, K He, X Lin, T Yu, J Li… - European Review for …, 2021 - europeanreview.org
OBJECTIVE: The pathogenesis of coronavirus disease 2019 (COVID-19) remains clear, and
no effective treatment exists. SARS-CoV-2 is the virus that causes COVID-19 and uses …

Immune repertoire sequencing reveals an abnormal adaptive immune system in COVID‐19 survivors

C Jia, Z Zhou, W Pan, P Zhang, M Yang… - Journal of Medical …, 2023 - Wiley Online Library
Accumulating evidence suggests that severe acute respiratory syndrome coronavirus 2
(SARS‐CoV‐2) impairs the adaptive immune system during acute infection. Still, it remains …

[HTML][HTML] Immunopathogenesis of Pneumonia in COVID-19

SD Alipoor, H Jamaati, P Tabarsi, E Mortaz - Tanaffos, 2020 - ncbi.nlm.nih.gov
Coronavirus disease 2019 (COVID-19), caused by a member of the Coronaviridae family
(SARS-CoV-2), was initially reported in Wuhan, China in late December and spread rapidly …

An Insight of comparison between COVID-19 (2019-nCoV disease) and SARS in pathology and pathogenesis

X Cai - 2020 - osf.io
COVID-19, a novel pathogenic coronavirus (2019-nCoV, now named SARS-CoV2) induced
disease, emerged in China and spread globally rapidly. 2019-nCoV (SARS-CoV2) shares …

On the whereabouts of SARS-CoV-2 in the human body: A systematic review

W Trypsteen, J Van Cleemput, W Snippenberg… - PLoS …, 2020 - journals.plos.org
Since SARS-CoV-2 appeared in the human population, the scientific community has
scrambled to gather as much information as possible to find good strategies for the …